Skip to Content

G I-150 (Ibandronate Sodium 150 mg (base))

Pill with imprint G I-150 is White, Capsule-shape and has been identified as Ibandronate Sodium 150 mg (base). It is supplied by Mylan Pharmaceuticals Inc..

Ibandronate is used in the treatment of prevention of osteoporosis; osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Ibandronate 150 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for G I-150

Ibandronate sodium 150 mg (base) G I-150

Ibandronate Sodium

Imprint
G I-150
Strength
150 mg (base)
Color
White
Size
14.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Bisphosphonates
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-5215
Inactive Ingredients
ammonia, ferrosoferric oxide, silicon dioxide, crospovidone, hydroxypropyl cellulose (type h), lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, shellac, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "G I-150"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.